665PNRF2 activation via PI3K/AKT/mTOR/RPS6 causes resistance to anti-HER2 agents among HER2 amplified gastric cancer. (23rd October 2018) - Gambardella, V; Gimeno-Valiente, F; Tarazona, N; Fleitas Kanonnikoff, T; Tolosa, P; Belda Moscardò, M; Garcia-Mico, B; Huerta, M; Roselló, S; Roda, D; Cervantes, A; Castillo, J